Lumida
/MLTX
⌘K
MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

MLTX
$12.51USD-5.08%-0.67 today

MARKET CAP

1.1B

P/E (TTM)

FWD P/E

DAY RANGE

$12 – $14

52W RANGE

$6
$63

Buying

9

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY6.90 M128.61 M+4.81 M+365.0%0.03%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUYNEW4.28 M83.34 M+4.28 M+0.0%0.05%
CA

Citadel Advisors LLC

Q2 2026

BUY2.46 M47.85 M+376.06 K+23.3%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.39 M27.60 M+297.91 K+49.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL1.16 M22.56 M+-209.79 K-11.6%0.03%
BI

Blackrock, Inc.

Q2 2026

BUY1.09 M21.32 M+72.94 K+11.9%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL912.72 K17.77 M+-152.90 K-10.5%0.02%
RT

Renaissance Technologies LLC

Q2 2026

BUY643.27 K12.52 M+366.50 K+142.8%0.02%
MM

Millennium Management LLC

Q2 2026

BUY636.19 K12.39 M+60.09 K+15.3%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY358.88 K6.99 M+312.70 K+711.7%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL27.00 K525.69 K+-450.14 K-94.1%0.02%
MG

Man Group Plc

Q2 2026

BUYNEW17.66 K343.86 K+17.66 K+0.0%0.00%
CC

Casdin Capital, LLC

Q2 2026

SELL0.000.00+-450.00 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-32.51 K-100.0%0.00%